For Research ParticipantsFind a Research Study

Title: Posttraumatic Stress Disorder Treatment via Videoconferencing

PI: JoAnn Difede, PhD

Institution: Weill Cornell Medical College

IRB#: 0802009646

IRB Expiration Date: 10/23/2012

Study Description: The goal of this study is to develop more effective treatments for posttraumatic stress disorder (PTSD) for individuals who develop PTSD in the course of their work. This study uses videoconferencing technology, such as Skype or Polycom to deliver a gold-standard psychotherapy treatment for PTSD. The main purpose of this study is to determine whether it is feasible to use telemedicine as a method to deliver psychotherapy treatment for PSTD for occupationally-related PTSD. Telemedicine refers to the use of specialized communication equipment to deliver and support health care when distance separates patients from appropriate health care providers. The psychotherapy treatment used in this study is called prolonged imaginal exposure. The study will also test whether combining D-Cycloserine (DCS) with this psychotherapy will improve its effectiveness. All participants in this study will receive 12-14 sessions of prolonged exposure psychotherapy delivered via videoconferencing technology, such as Skype or Polycom. Participants will also be randomly assigned to receive the drug (DCS) or a placebo (sugar pill).

Involvement: : Receiving 12-14 sessions of prolonged exposure therapy, interviews, questionnaires, taking an active pill (DCS) or a sugar pill (placebo)

Age: 18-70 years

Eligibility: Diagnosis of posttraumatic stress disorder (PTSD) following an occupationally-related trauma (e.g. military service, police work, EMS work, fire fighting)

Commitment: 12-14 sessions over 4 months with a 6-month follow-up

Contact: : Dr. Megan Olden at 212-821-0786 or meo9011@med.cornell.edu

Sponsor(s): Internal